Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Amneal Pharmaceuticals with status Current. The shortage was first posted on Apr 10, 2020.
Shortage details
- Status
- Current
- Company
- Amneal Pharmaceuticals
- Package NDC
- 70121-1388-1
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)
- Initial Posting
- Apr 10, 2020